omega-3 supplement in attention deficit hyperactivity disorder
Phase 2
- Conditions
- Adult ADHD (Attention-deficit hyperactivity disorder ).Hyperkinetic disorder, unspecified
- Registration Number
- IRCT2016060128182N2
- Lead Sponsor
- Kurdistan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 66
Inclusion Criteria
Inclusion Criteria: Diagnosis of ADHD based on DSMIV age between 6-12
Exclusion Criteria
receiving of omega3 suplement during past 6 months; presence of seizures; mental retardation; having any psychiatric disorders
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in Attention-deficit symptoms. Timepoint: Baseline, second, fourth and eighth weeks after intervention. Method of measurement: Conner's and ADHD Rating Scales.;Improvement in Impulsivity symptoms. Timepoint: Baseline, third and sixth weeks after intervention. Method of measurement: Conner's and ADHD Rating Scales–Self-Report.;Improvement in hyperactivity symptome. Timepoint: Baseline, third and sixth weeks after intervention. Method of measurement: Conner's and ADHD Rating Scales–Self-Report.
- Secondary Outcome Measures
Name Time Method Severity of ADHD symptoms. Timepoint: Baseline, second, fourth and eighth weeks after intervention. Method of measurement: ADHD Rating Scales, CGI.;Side effect. Timepoint: second, fourth and eighth weeks after intervention. Method of measurement: Side effects quesionnaire.